logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11911461 B1

PDFFull Text
Date of Patent:
Feb. 27, 2024

Filed:

May. 05, 2023

Adjuvanted vaccines containing modified s1 spike protein of sars-cov-2 variant c.1.2 for subcutaneous administration and methods of use

Applicant:

D4 Labs, Llc, Pacific Grove, CA (US);

Inventors:

David Craig Wright, Pacific Grove, CA (US);

Michael Bowe, Marina, CA (US);

Emily Wright, Covina, CA (US);

Peter Pushko, Frederick, MD (US);

Assignee:

D4 Labs, LLC, Pacific Grove, CA (US);

Attorney:

King & Spalding

Primary Examiner:

Barry A Chestnut

Int. Cl.
CPC ...
A61K 39/215 (2006.01); A61K 39/00 (2006.01); A61K 39/42 (2006.01); A61P 31/14 (2006.01); C07K 16/10 (2006.01); A61P 37/04 (2006.01);
U.S. Cl.
CPC ...
A61K 39/215 (2013.01); A61P 37/04 (2018.01); A61K 2039/545 (2013.01); A61K 2039/55555 (2013.01);
Abstract

Disclosed herein are adjuvanted protein vaccines comprising: a SARS-CoV-2 variant C.1.2 modified S1 Spike protein sequence and a non-phospholipid liposome, wherein the protein is encapsulated within the non-phospholipid liposome. The adjuvanted protein vaccines are suitable for subcutaneous administration. Also disclosed herein are modified spike protein sequences containing SARS-CoV-2 variant C.1.2 modified S1 Spike proteins and methods of use of the vaccines and sequences.

Find Patent Forward Citations

Quick Actions:

Wright, David. (2024). Adjuvanted vaccines containing modified s1 spike protein of sars-cov-2 variant c.1.2 for subcutaneous administration and methods of use (U.S. Patent No. 11911461). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11911461

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…